Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Basel Medical GroupBMGL -24.94%17 Net Margin % is 3.25% as of Dec. 2025, which is 82% below its 10-year median of 18.47. GuruFocus rates BMGL with a GF Score™ of 17/100. The stock has 3 warning signs investors should review. Among 665 Healthcare Providers & Services companies, Basel Medical Group ranks worse than 88.57% on this metric.
The historical rank and industry rank for Basel Medical Group's Net Margin % or its related term are showing as below:
BMGL'
s Net Margin % Range Over the Past 10 Years
Min: -93.95 Med: 18.47 Max: 20.63
Current: -69.33
BMGL's Net Margin % is ranked worse than 88.57% of 665
companies
in the Healthcare Providers & Services industry
Industry Median: 2.9
vs BMGL: -69.33
Basel Medical Group (NAS:BMGL) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Basel Medical Group Net Margin % Related Terms
Basel Medical Group Net Margin % Historical Data
* Premium members only.
The historical data trend for Basel Medical Group's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Basel Medical Group's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Basel Medical Group Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Basel Medical Group's Net Margin % distribution charts can be found below:
* The bar in red indicates where Basel Medical Group's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Basel Medical Group (BMGL) has a Net Margin % of 3.25% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Basel Medical Group and its competitors. This is 82% below median its historical median of 18.47. According to the industry distribution chart, Basel Medical Group ranks #589 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 88.6%.
Is Basel Medical Group's Net Margin % too high?
Basel Medical Group's current Net Margin % of 3.25% is 82% below median its 10-year median of 18.47. The Healthcare Providers & Services industry median Net Margin % is 2.90. Basel Medical Group's value of 3.25% is 12.1% above this industry median. Based on the distribution chart, Basel Medical Group ranks #589 out of 665 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Basel Medical Group has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Basel Medical Group's Net Margin % compare to AMS and HLYK?
According to the Healthcare Providers & Services industry distribution chart, Basel Medical Group ranks #589 out of 665 companies for Net Margin %. This places Basel Medical Group in the lower half of its industry. The industry median Net Margin % is 2.90. Basel Medical Group's value of 3.25% is 12.1% above this benchmark. While the company's 10-year median is 18.47 vs. the industry median of 2.90, Basel Medical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.90, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Basel Medical Group's current Net Margin % of 3.25% is 12.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Basel Medical Group and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Basel Medical Group's current Net Margin % is 3.25%, which is 82% below median its own 10-year median of 18.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Basel Medical Group stock overvalued right now?
Basel Medical Group (BMGL) has a current Net Margin % of 3.25%. The current Net Margin % is 3.25%, which is 82% below median its 10-year median of 18.47 and 12.1% above the Healthcare Providers & Services industry median of 2.90. Basel Medical Group's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Basel Medical Group (BMGL), the current Net Margin % is 3.25% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. The services provided by clinics include, but are not limited to, consultation, medical diagnosis and medical or surgical treatments for orthopedic, trauma, sports medicine, general practice, health screening, mental health, women's health and neurosurgical conditions and clinics are equipped with the facilities needed to perform a variety of procedures on site and minor surgical services. Key revenue is generated from Singapore.
17GF Score
Get the complete analysis for BMGL
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BMGL has been successfully added to your 
